These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34383409)

  • 21. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
    Le Bourgeois M
    Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapeutic strategies for treating
    Shao X; Xie Y; Zhang Y; Liu J; Ding Y; Wu M; Wang X; Deng X
    Expert Opin Drug Discov; 2020 Dec; 15(12):1403-1423. PubMed ID: 32880507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 27. Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.
    Clark ST; Guttman DS; Hwang DM
    FEMS Microbiol Lett; 2018 Mar; 365(6):. PubMed ID: 29401362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
    Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
    Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.
    Qin S; Xiao W; Zhou C; Pu Q; Deng X; Lan L; Liang H; Song X; Wu M
    Signal Transduct Target Ther; 2022 Jun; 7(1):199. PubMed ID: 35752612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Smith S; Ratjen F; Remmington T; Waters V
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient.
    Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D
    J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
    Driscoll JA; Brody SL; Kollef MH
    Drugs; 2007; 67(3):351-68. PubMed ID: 17335295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis.
    López-Causapé C; Oliver A
    Future Microbiol; 2017 Dec; 12():1445-1448. PubMed ID: 29068237
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.
    Gooderham WJ; Hancock RE
    FEMS Microbiol Rev; 2009 Mar; 33(2):279-94. PubMed ID: 19243444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
    Jarjees KK
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.